Inventor
Elena Dneprovskaia
Inventor
San Diego, CA, US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes14%
C07BGeneral methods of organic chemistry10%
PatentTitleYear
8,481,536'Benzotriazine inhibitors of kinases'20138,372,971'Heterocyclic compounds and methods of use'20138,084,618'Heterocyclic compounds and methods of use'20118,030,487'2-amino—5-substituted pyrimidine inhibitors'20117,691,858'Kinase inhibitors and methods of use thereof'20107,652,051'Heterocyclic compounds and methods of use'20107,456,176'Benzotriazine inhibitors of kinases'20087,208,493'Vasculostatic agents and methods of use thereof'20077,098,336'FXR NR1H4 nuclear receptor binding compounds'20067,034,046'NR1H4 nuclear receptor binding compounds'20066,974,830'NR1H4 nuclear receptor binding compounds'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2013Based in San Diego, CA, US· patent location history
2006Patents assigned to PHENEX PHARMACEUTICALS AG (2)· patent assignee history
2007–2013Patents assigned to TARGEGEN INC (8)· patent assignee history
2011–2013Patents assigned to DNEPROVSKAIA ELENA (3)· patent assignee history
2011–2013Patents assigned to WRASIDLO WOLFGANG (3)· patent assignee history
2013Patents assigned to BARRETT KATHY (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TARGEGEN INC | 8 | 2007–2013 |
| DNEPROVSKAIA ELENAself | 3 | 2011–2013 |
| WRASIDLO WOLFGANG | 3 | 2011–2013 |
| PHENEX PHARMACEUTICALS AG | 2 | 2006 |
| BARRETT KATHY | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 11 | 2005–2013 |